Skip to main content
Banner - Research & Funding

University of Minnesota PS-OC

Center for Modeling Tumor Cell Migration Mechanics

Cell migration is a common feature of high-grade cancer, with invasion and metastasis being primary causes of cancer related death. As a result, this PS-OC is focusing on understanding the fundamental mechanics and chemistry of how cells generate forces to move through complex and mechanically challenging tumor microenvironments.

The organizing framework of the PS-OC is to then directly target the mechanical machinery and structural elements that drive cell migration. As it is these elements that serve as the most downstream convergence point of the upstream genetic alterations, disruption of these critical elements provides viable, clinically-relevant targets.

By focusing directly on the “nuts and bolts” of cell migration, PS-OC investigators will be targeting the most vital and non-redundant part of the system. Specifically, they are using integrated modeling and experiments to investigate the molecular mechanics of cell migration and how the tumor microenvironment regulates disease progression as a function of the underlying carcinoma genetics.

The PS-OC is experimentally testing a computational cell migration simulator for the mechanical dynamics of cell migration that will ultimately be used to:

  • Identify novel drug targets/target combinations in silico

  • Define molecular mechanical subtypes of tumors for patient stratification

  • Guide the engineering of in vitro microsystems and in vivo animal models to better mimic the human disease

  • Simulate tumor progression under different potential treatment strategies.

The PS-OC is also developing a simulator-driven reverse genetics approach to elucidate the functional mechanical consequences of driver mutations and seek to manipulate the physical characteristics of a tumor to simultaneously bias against immune suppressor cells and promote the antitumor immune response.

Learn more at the University of Minnesota PS-OC website.

Projects

Project 1: Physical Modeling and Dynamics of Tumor Cell Migration Mechanics

A key feature of highly aggressive cancers is their invasiveness, where transformed cells disseminate by crawling through the local micro-environment, ultimately causing death as the tumor invades and metastasizes. If these processes of cell motility could be suppressed, it would potentially extend lifespan and increase the potential effectiveness for local and global therapeutic treatments. However,researchersdo not adequately understand the mechanical and chemical basis of cancer cell migration in complex and mechanically challenging microenvironments.

The goal of this project is to develop and use a mathematical/computational model that will allow us to simulate cancer migration on a computer, and, in the longer-term, perform virtual in silico drug screening.

Specifically, this project is mechanically parameterizing glioblastoma (GBM) and pancreatic ductal adenocarcinoma (PDA) tumor cell migration so that patient outcomes can be predicted and new therapeutic strategies identified.

Employing physical modeling for whole cell model migration, PS-OC investigators developed a “Cell Migration Simulator, v1.0,” (CMS1.0) to capture fundamental intracellular and extracellular mechanical processes regulating cell migration. CMS1.0 is being used to:

  • Mechanically parameterize tumor heterogeneity
  • Bias immune-cancer cell interaction away from suppression and toward killing
  • Elucidate proto-oncogene mechanism.

The PS-OC is also further developing CMS1.0 to include more explicit F-actin dynamics, cell mechanics, and environmental fiber mechanics. In the process, PS-OC investigators are building a physical sciences-based, patient-oriented approach toward understanding and controlling a key driver of cancer progression, cell migration.

Thus, the project is establishing the quantitative framework necessary to develop a model-driven approach to brain and pancreatic cancer invasion, so that therapies can be designed and engineered for better, more predictable outcomes.

Project 2: Cell Migration in Mechanically Complex Microenvironments

Cancers are complex systems commonly associated with a robust fibroinflammatory stromal response, or desmoplastic reaction. This is highly relevant as it is now recognized that, in many solid tumors, the stromal compartment and its local microenvironments significantly influence disease progression.

Through disease progression this desmoplastic reaction continues and often intensifies, offering critical support to malignant cells as they progress to invasive and often fully metastastic disease while also providing drug-free sanctuaries that limit access of small molecule therapies. Likewise, even the earliest stages of disease are associated with a robust immune reaction that evolves with disease progression.

Here tumor microenvironments appear to form sanctuaries for immune evasion and in fact are comprised, in part, of infiltrated immune cells that have been subverted to act as active collaborators that enable tumor progression. Interestingly, while robust biochemical stimuli are present in tumors, they are not the only factor. These microenvironments also provide robust physical cues that conspire to promote disease progression. For instance, in solid tumors there are fundamental roles of extracellular matrix stiffness, composition and architecture that profoundly influence outcome. However, to date, the molecular and physical mechanisms by which matrix stiffness and architecture, and their relative contributions, influence tumor cell behavior are not well known.

PS-OC researchers are using specific and integrated experiments and modeling to explicitly investigate the physical and molecular mechanisms by which the tumor microenvironment regulates disease progression as a function of the underlying carcinoma genetics.

Quantitative analysis and parameterization of data is facilitating model development and model predictions are being tested experimentally. Specifically, they are employing a series of 2D and 3D assays with varying stiffness, architecture of increasing complexity, and multiscale network modeling to parse out the relative contributions of contact guidance cues and durotactic effects in complex microenvironments. Integration of chemical gradients is being used to parse out dominance, antagonism, or synergy between chemical and physical cues.

The PS-OC hypothesizes that physical cues in the cellular microenvironment drive communication between different tumor cell populations and regulate immune cell infiltration and function. Thus, it seeks to identify regimes where manipulating operant physical characteristics of a tumor reduces carcinoma cell advancement while simultaneously hampering immune evasion and promoting the antitumor response.

Cores

Core 1: Cellular Microenvironment Engineering

The Cell Microenvironment Engineering Core provides enabling technologies and develops new methods for controlling the cellular microenvironment and measuring its effects on cancer cell migration. The primary goals of the core are:

  • Probe microenvironmental regulators of cell migration to inform mathematical models
  • Examine cell migration within a physiologically relevant context
  • Develop highly parallelized platforms for high throughput studies.

Technologies tools for controlling the mechanical environment, cell and environment architecture, cell organization within the microenvironment, chemical gradients, and extracellular chemistry, as well as resources for measuring cell migration and cell force generation. Additionally, tools are being developed for high-throughput cell migration measurement and high-throughput tissue isolation.

Core 2: Cell and Whole Animal Genome Engineering

The Cell and Whole Animal Genetic Engineering Core provides the PS-OC with genetically engineered cell lines and mice for analyzing cell and/or tumor behavior under a variety of conditions. The core brings together expertise from highly trained mouse and somatic cell geneticists, and is generating cohorts of mice that reliably develop pancreatic, glioma or medulloblastoma tumors due to the inheritance of germline transgenes, mutant alleles in their endogenous locus, or due to transposon-mediated gene delivery to the brain.

The core also supports PS-OC studies involving the perturbation of genetic events and is developing additional models as needed. Models of glioma and medulloblastoma initiated in mice by transposon delivery of shRNA and cDNAs from the core are being used by PS-OC scientists.

It also provides genetically altered human cancer cell lines for PS-OC projects. These cell lines harbor loss of function mutations or specific single nucleotide variants (SNV) in genes of interest. This resources is being produced using TAL endonuclease or CRISPR/Cas9 gene targeting, without or with oligonucleotide substrates, to create “knockout” cell lines due to imprecise non-homologous end joining (NHEJ) in the former case, or SNVs via homology directed repair (HDR) in the latter case.

Education and Outreach Unit

If the computer had human-like intelligence, then researchers could engage in discussion with it regarding the essential features of the model. Since such computers are not on the immediate horizon, the PS-OC has started to explore programming humans to act as the agents in the simulation. Such programming can be physically demanding and may involve violent collisions as dictated by the level of thermal forces and diffusion.

Thus, initial exploration involves a collaboration with a professional dance company, Black Label Movement (directed by Carl Flink). Dancers, who are referred to as “movers”, are now highly trained in diffusion reaction, self-assembly, and forces in a collaboration called the “Moving Cell” project. These movers rapidly assimilate model rules and carry out human-scale simulations over a few minutes. This process is known as “bodystorming” (where bodies and minds work together to rapidly construct and deconstruct models).

Bodystorming engages PS-OC researchers, clinicians, patients, and caregivers. The PS_OC is also working with Carole Baas, the PS-ON National Advocate, to develop a new bodystorming experience focused on the experience of cancer survivors.

The interactions facilitated by bodystorming use human movement as a facilitator to break down disciplinary language barriers between cancer researchers, patients, clinicians, and caregivers enabling substantive new discourse that accelerates the science.

Investigators

David Odde, Ph.D.

David Odde, Ph.D.
University of Minnesota

Dr. David Odde is a professor of biomedical engineering at the University of Minnesota who studies the mechanics of cell division, polarization, and migration. Trained academically as a chemical engineer, he joined the newly created Department of Biomedical Engineering at the University of Minnesota in 1999.

In his research, Odde’s group builds computer models of cellular and molecular self-assembly and force-generation-dissipation dynamics, as well as tests the models experimentally using digital microscopic imaging of cells ex vivo and in engineered microenvironments. Current applications include the modeling of chemotherapeutic effects on cell division, molecular mechanisms of neurodegeneration, and migration of cancer cells through complex microenvironments such as the brain. Ultimately, his group seeks to use the models to perform virtual screens of potential therapeutic strategies. Dr. Odde is an elected Fellow of the American Institute for Medical and Biological Engineering (AIMBE) and of the Biomedical Engineering Society (BMES).

David Largaespada, Ph.D.

David Largaespada, Ph.D.
University of Minnesota

Dr. David Largaespada is an authority on mouse genetics, gene modification and cancer genes. He received his B.S. in Genetics and Cell Biology from the University of Minnesota in 1987 and his Ph.D. in Molecular Biology with Dr. Rex Risser at the University of Wisconsin-Madison in 1992. He spent five years as a postdoctoral fellow in Frederick, Maryland at the National Cancer Institute. Dr. Largaespada joined the faculty of the University of Minnesota in late 1996 and is currently a Full Professor in the Department of Genetics, Cell Biology and Development and the Department of Pediatrics at the University of Minnesota. He also serves as associate director for Basic Science at the University of Minnesota Masonic Cancer Center.

Dr. Largaespada is working to exploit insertional mutagenesis for cancer gene discovery and functional genomics in the mouse. He has pioneered the use of a vertebrate-active transposon system, called Sleeping Beauty (SB), for insertional mutagenesis in mouse somatic and germline cells, and for gene therapy. Using SB he has developed a powerful method to find new cancer genes using transgenic mouse models.

Steven Rosenfeld, M.D., Ph.D.

Steven Rosenfeld, M.D., Ph.D.
Mayo Clinic

Dr. Rosenfeld has over 25 years of experience as a widely published, NIH-funded investigator in the biochemistry of molecular myosin motors, more recently applied translationally to the problem of glioma dispersion and proliferation.

He also been an investigator in neuro-oncology for over twenty years, including as Director of the Brain Tumor Research and Treatment Program at the University of Alabama at Birmingham, as Principal Investigator in a brain tumor program project grant and as Director of the UAB Brain Cancer SPORE, as Chief of Neuro-Oncology at Columbia University, and most recently, as the Melvin H. Burkhardt Professor of Neuro-Oncology and Director of the Brain Tumor Research Center of Excellence at the Cleveland Clinic, as Co-Director of the Neuro-Oncology Program at the Case Comprehensive Cancer Center , as a member of the External Advisory Boards of the Mayo Clinic Cancer Center and the Mayo Clinic and University of Alabama at Birmingham Brain Cancer SPORE programs, and as a member of the Steering Committee of the Adult Brain Tumor Consortium (ABTC).

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “University of Minnesota PS-OC was originally published by the National Cancer Institute.”